Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for recurrent genital herpes
Foster City: Gilead Sciences and Assembly Biosciences have announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, including long-acting investigational…